Events

Blog  |  Events  |  News 

ELRIG Drug Discovery - Liverpool

5 - 6 November 2019

XenoGesis will be exhibiting at ELRIG’s flagship conference Drug Discovery 2019 at the ACC in Liverpool on the 5th and 6th November. This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing how we got to where we are now and setting the challenges for discovering the drugs of the future. Rachel Hemsley, Global Head of Business Development at XenoGesis will be attending and can be found on booth G8.

Click here for more information
CPhI Worldwide - Frankfurt, Germany

5-7 November 2019

Richard Weaver will be attending CPhI Worldwide, the world's largest pharmaceutical exhibition, which event houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals.

Click here for more information
TTO Conference - Barcelona

7 November 2019

Richard Weaver will be presenting on ‘Drug Discovery – common mistakes and key recommendations for success’ at the Spanish Network of Innovation in Healthcare System (ITEMAS) annual general assembly in Barcelona.

Pharma Integrates - London

18-19 November 2019

Richard Weaver will joining the panel in the session on 'Size matters - out with the small molecules?' at this year's Pharma Integrates. The unique event brings together key industry leaders across the pharmaceutical pipeline to share insights and create debate on crucial topics that influence the future of patient outcomes.

Click here for more information
12th EBF Open Symposium - Barcelona

20-22 November 2019

Pete White, Director of Bioanalytical Development at XenoGesis, will be attending the 12th EBF Open Symposium entitled 'Imagine a new Bioanalytical Earthrise'. The Open Symposium is a landmark event to bioanalytical discussions in the EU and has created a forum for people working in bioanalysis.

Click here for more information
LD3 Steering Group - University of Leicester

3 December 2019

Richard Weaver will be attending the LD3 Steering Group meeting on the 3rd December. The LD3 Steering Group aims to progress the world leading basic biomedical and clinical research performed within the College of Life Sciences, into translational projects aimed at developing novel clinical interventions – therapeutics, diagnostics and devices.

Genesis 2019 - London

11 December 2019

Rachel Hemsley will be attending this year's Genesis conference in London. Under the theme of 'New Horizons in Life Science and Healthcare', the 19th annual conference will engage all the key elements for those active in R&D, finance, policy making and service provision across the life sciences and digital and health technology fields.

Click here for more information